1. Home
  2. IOVA vs PAX Comparison

IOVA vs PAX Comparison

Compare IOVA & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.77

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Patria Investments Limited

PAX

Patria Investments Limited

HOLD

Current Price

$13.04

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
PAX
Founded
2007
1988
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
2.2B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
IOVA
PAX
Price
$3.77
$13.04
Analyst Decision
Buy
Buy
Analyst Count
10
2
Target Price
$9.00
$18.00
AVG Volume (30 Days)
13.1M
846.5K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
4.65%
EPS Growth
14.84
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$51.55
$13.00
Revenue Next Year
$37.55
$15.87
P/E Ratio
N/A
$25.65
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$9.63
52 Week High
$5.63
$17.80

Technical Indicators

Market Signals
Indicator
IOVA
PAX
Relative Strength Index (RSI) 52.44 62.44
Support Level $2.02 $12.81
Resistance Level $4.34 $14.53
Average True Range (ATR) 0.30 0.40
MACD 0.02 0.16
Stochastic Oscillator 51.69 98.32

Price Performance

Historical Comparison
IOVA
PAX

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

Share on Social Networks: